Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
FDA's Approval Summary of the First Biosimilar to Natalizumab for the Treatment of Multiple Sclerosis and Crohn's Disease.
Journal: Journal of clinical pharmacology
Published: March 31, 2026
Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative.
Journal: Clinical pharmacology and therapeutics
Published: September 09, 2025
Development of Celiac Disease Therapeutics: The Sixth Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics Workshop.
Journal: Gastro hep advances
Published: August 29, 2022
The benefits, limitations and opportunities of preclinical models for neonatal drug development.
Journal: Disease models & mechanisms
Published: April 25, 2022
Effect of reading to preterm infants on measures of cardiorespiratory stability in the neonatal intensive care unit.
Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: March 30, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026